{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,14]],"date-time":"2026-05-14T12:12:11Z","timestamp":1778760731287,"version":"3.51.4"},"reference-count":31,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalmicrobiologyandinfection.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Microbiology and Infection"],"published-print":{"date-parts":[[2026,6]]},"DOI":"10.1016\/j.cmi.2026.02.017","type":"journal-article","created":{"date-parts":[[2026,2,24]],"date-time":"2026-02-24T17:00:07Z","timestamp":1771952407000},"page":"998-1005","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Benznidazole therapy is cost-saving compared with no treatment for indeterminate chronic Chagas disease in the Spanish healthcare setting"],"prefix":"10.1016","volume":"32","author":[{"given":"Philip Erick","family":"Wikman-Jorgensen","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jara","family":"Llenas-Garc\u00eda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Clara","family":"Crespillo-And\u00fajar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jose A.","family":"Perez-Molina","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.cmi.2026.02.017_bib1","first-page":"284","article-title":"2023 Chagas disease and RAISE study collaborators. Global, regional, and national burden of Chagas disease, 1990\u20132023: a systematic analysis for the global burden of disease study 2023","volume":"26","author":"Gbd","year":"2025","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.cmi.2026.02.017_bib2","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1016\/S0140-6736(17)31612-4","article-title":"Chagas disease","volume":"391","author":"P\u00e9rez-Molina","year":"2018","journal-title":"Lancet"},{"key":"10.1016\/j.cmi.2026.02.017_bib3","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/B978-0-12-385863-4.00002-2","article-title":"Acute and congenital Chagas disease","volume":"75","author":"Bern","year":"2011","journal-title":"Adv Parasitol"},{"key":"10.1016\/j.cmi.2026.02.017_bib4","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pntd.0010386","article-title":"Use of benznidazole to treat chronic Chagas disease: an updated systematic review with a meta-analysis","volume":"16","author":"Crespillo-And\u00fajar","year":"2022","journal-title":"PLoS Negl Trop Dis"},{"key":"10.1016\/j.cmi.2026.02.017_bib5","doi-asserted-by":"crossref","first-page":"1035","DOI":"10.1007\/s40264-018-0696-5","article-title":"Safety profile of benznidazole in the treatment of chronic Chagas disease: experience of a referral centre and systematic literature review with meta-analysis","volume":"41","author":"Crespillo-And\u00fajar","year":"2018","journal-title":"Drug Saf"},{"key":"10.1016\/j.cmi.2026.02.017_bib6","first-page":"47","article-title":"Estimating Chagas disease prevalence and number of underdiagnosed, and undertreated individuals in Spain","volume":"102284","author":"Navarro","year":"2022","journal-title":"Travel Med Infect Dis"},{"key":"10.1016\/j.cmi.2026.02.017_bib7","first-page":"33","article-title":"Chagas disease in Latin America: an epidemiological update based on 2010 estimates","volume":"90","author":"WHO","year":"2015","journal-title":"Wkly Epidemiol Rec"},{"key":"10.1016\/j.cmi.2026.02.017_bib8","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pntd.0005033","article-title":"Estimating the burden of Chagas disease in the United States","volume":"10","author":"Manne-Goehler","year":"2016","journal-title":"PLoS Negl Trop Dis"},{"key":"10.1016\/j.cmi.2026.02.017_bib9","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pntd.0003540","article-title":"Prevalence of Chagas disease in Latin-American migrants living in Europe: a systematic review and meta-analysis","volume":"9","author":"Requena-M\u00e9ndez","year":"2015","journal-title":"PLoS Negl Trop Dis"},{"key":"10.1016\/j.cmi.2026.02.017_bib10","first-page":"513","article-title":"Chagas disease in Europe","volume":"8","author":"Gonzalez-Sanz","year":"2023","journal-title":"Trop Med Infect Dis"},{"key":"10.1016\/j.cmi.2026.02.017_bib11","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pntd.0012407","article-title":"Prevention of congenital Chagas disease by trypanocide treatment in women of reproductive age: a meta-analysis of observational studies","volume":"18","author":"Moraes","year":"2024","journal-title":"PLoS Negl Trop Dis"},{"key":"10.1016\/j.cmi.2026.02.017_bib12","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1186\/s12889-022-14938-4","article-title":"Diagnostic pathways of Chagas disease in Spain: a qualitative study","volume":"23","author":"Iglesias-Rus","year":"2023","journal-title":"BMC Public Health"},{"key":"10.1016\/j.cmi.2026.02.017_bib13","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pntd.0011757","article-title":"The economic burden of Chagas disease: a systematic review","volume":"17","author":"Andrade","year":"2023","journal-title":"PLoS Negl Trop Dis"},{"key":"10.1016\/j.cmi.2026.02.017_bib14","author":"INE"},{"key":"10.1016\/j.cmi.2026.02.017_bib15","doi-asserted-by":"crossref","first-page":"e439","DOI":"10.1016\/S2214-109X(17)30073-6","article-title":"Cost-effectiveness of Chagas disease screening in Latin American migrants at primary health-care centres in Europe: a Markov model analysis","volume":"5","author":"Requena-M\u00e9ndez","year":"2017","journal-title":"Lancet Glob Health"},{"key":"10.1016\/j.cmi.2026.02.017_bib16","unstructured":"Advisory Committee for the Financing of Pharmaceutical Benefits of the National Health System. Guidelines for the economic evaluation of medicines. Ministry of Health; n.d. https:\/\/www.sanidad.gob.es\/areas\/farmacia\/comitesAdscritos\/prestacionFarmaceutica\/docs\/20240227_CAPF_Guia_EE_definitiva.pdf. [Accessed 03 August 2025]."},{"key":"10.1016\/j.cmi.2026.02.017_bib17","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pntd.0009680","article-title":"Predictors of development of cardiac and digestive disorders among patients with indeterminate chronic Chagas disease","volume":"15","author":"Nunes Da Costa","year":"2021","journal-title":"PLoS Negl Trop Dis"},{"key":"10.1016\/j.cmi.2026.02.017_bib18","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2020.15072","article-title":"Risk of Chronic cardiomyopathy among patients with the acute phase or indeterminate form of Chagas disease: a systematic review and meta-analysis","volume":"3","author":"Chadalawada","year":"2020","journal-title":"JAMA Netw Open"},{"key":"10.1016\/j.cmi.2026.02.017_bib19","doi-asserted-by":"crossref","first-page":"5466","DOI":"10.1002\/ehf2.13648","article-title":"Mortality risk in chronic Chagas cardiomyopathy: a systematic review and meta-analysis","volume":"8","author":"Chadalawada","year":"2021","journal-title":"ESC Heart Fail"},{"key":"10.1016\/j.cmi.2026.02.017_bib20","doi-asserted-by":"crossref","DOI":"10.1186\/s13071-016-1315-x","article-title":"Increased mortality attributed to Chagas disease: a systematic review and meta-analysis","volume":"9","author":"Cucunub\u00e1","year":"2016","journal-title":"Parasit Vectors"},{"key":"10.1016\/j.cmi.2026.02.017_bib21","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1590\/S0037-86821994000400005","article-title":"Estudo radiol\u00f3gico longitudinal do es\u00f4fago, em \u00e1rea end\u00eamica de doen\u00e7a de Chagas, em um per\u00edodo de 13 anos","volume":"27","author":"Castro","year":"1994","journal-title":"Rev Soc Bras Med Trop"},{"key":"10.1016\/j.cmi.2026.02.017_bib22","first-page":"9","article-title":"Chagas disease-related mortality in Spain, 1997 to 2018","volume":"1991","author":"Ramos-Rincon","year":"2021","journal-title":"Microorganisms"},{"key":"10.1016\/j.cmi.2026.02.017_bib23","series-title":"R Core Team. R: a Language and Environment for statistical computing","year":"2023"},{"key":"10.1016\/j.cmi.2026.02.017_bib24","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1016\/j.jval.2013.02.002","article-title":"Consolidated Health Economic Evaluation Reporting Standards (CHEERS)\u2014explanation and Elaboration: a report of the ISPOR health economic evaluation publication guidelines good reporting practices task force","volume":"16","author":"Husereau","year":"2013","journal-title":"Value Health"},{"key":"10.1016\/j.cmi.2026.02.017_bib25","first-page":"1","volume":"108","author":"Consejer\u00eda de salud. Orden de 24 de mayo de","year":"2024","journal-title":"Bol Junta Andal"},{"key":"10.1016\/j.cmi.2026.02.017_bib26","article-title":"del Instituto de Salud Carlos III, O.A., M.P., por la que se modifica el Anexo de la Resoluci\u00f3n de 3 de abril de 2019, por la que se establecen los precios p\u00fablicos correspondientes a la prestaci\u00f3n de servicios y actividades del organismo","year":"2023","journal-title":"Bol Estado"},{"key":"10.1016\/j.cmi.2026.02.017_bib27","unstructured":"Conseller\u00eda Salut i Consum. Resoluci\u00f3n del Director General del Servei de Salut de modificaci\u00f3n de la Orden de la Consellera de Salut i Consum de 22 de diciembre de 2006, por la que se establecen los precios p\u00fablicos que han de aplicar los centros sanitarios de la red p\u00fablica de les Illes Balears para la prestaci\u00f3n de servicios sanitarios cuando existan terceros obligados al pago o usuarios sin derecho a la asistencia sanitaria de la Seguridad Social. 2021. https:\/\/www.caib.es\/eboibfront\/es\/2020\/11314\/seccion-iii-otras-disposiciones-y-actos-administra\/472. [Accessed 20 MAY 2025]."},{"key":"10.1016\/j.cmi.2026.02.017_bib28","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1016\/j.recesp.2013.12.016","article-title":"Health care and nonhealth care costs in the treatment of patients with symptomatic chronic heart failure in Spain","volume":"67","author":"Delgado","year":"2014","journal-title":"Rev Esp Cardiol (Engl Ed"},{"key":"10.1016\/j.cmi.2026.02.017_bib29","first-page":"31","article-title":"Analysis of the Chagas disease situation in Japan: a cross sectional study and cost-effectiveness analysis of a Chagas disease screening program","volume":"100574","author":"Iglesias Rodr\u00edguez","year":"2023","journal-title":"Lancet Reg Health West Pac"},{"key":"10.1016\/j.cmi.2026.02.017_bib30","first-page":"16","article-title":"Cost-effectiveness analysis of screening for congenital Chagas disease in a non-endemic area","volume":"8707","author":"Marraffa","year":"2025","journal-title":"Nat Commun"},{"key":"10.1016\/j.cmi.2026.02.017_bib31","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pntd.0009281","article-title":"Chagas disease screening in pregnant Latin American women: adherence to a systematic screening protocol in a non-endemic country","volume":"15","author":"Llenas-Garc\u00eda","year":"2021","journal-title":"PLoS Negl Trop Dis"}],"container-title":["Clinical Microbiology and Infection"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1198743X26000753?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1198743X26000753?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,14]],"date-time":"2026-05-14T11:49:19Z","timestamp":1778759359000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1198743X26000753"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6]]},"references-count":31,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2026,6]]}},"alternative-id":["S1198743X26000753"],"URL":"https:\/\/doi.org\/10.1016\/j.cmi.2026.02.017","relation":{},"ISSN":["1198-743X"],"issn-type":[{"value":"1198-743X","type":"print"}],"subject":[],"published":{"date-parts":[[2026,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Benznidazole therapy is cost-saving compared with no treatment for indeterminate chronic Chagas disease in the Spanish healthcare setting","name":"articletitle","label":"Article Title"},{"value":"Clinical Microbiology and Infection","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cmi.2026.02.017","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 European Society of Clinical Microbiology and Infectious Diseases. Published by Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}